Welcome to our dedicated page for Mitesco SEC filings (Ticker: MITI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding Mitesco’s regulatory trail isn’t straightforward: one minute you’re parsing margins at newly acquired compound pharmacies, the next you’re assessing capital outlays for cloud racks. Investors who search “Mitesco SEC filings explained simply” or wonder “What does the company report about each segment?” often face hundreds of pages blending healthcare and technology rules. Stock Titan removes that friction by translating dense disclosures into clear insight.
You’ll find every Mitesco quarterly earnings report 10-Q filing, a Mitesco annual report 10-K simplified, and the latest Mitesco 8-K material events explained. Our AI highlights segment revenue swings, acquisition details, and related-party transactions so understanding Mitesco SEC documents with AI takes minutes, not hours. Need trading activity? Mitesco insider trading Form 4 transactions flow in as soon as they hit EDGAR—delivering Mitesco Form 4 insider transactions real-time for rapid analysis. We also link earnings-call soundbites to figures in the filings, giving you a seamless Mitesco earnings report filing analysis.
- AI-powered summaries written in plain English
- Real-time alerts for Mitesco executive stock transactions Form 4
- Side-by-side cash-flow and segment revenue charts
- Full document downloads in PDF or Excel
Curious about pay packages? Pull a Mitesco proxy statement executive compensation table with one click. Tracking risk factors tied to new data centers? They’re flagged inside each note. From acquisition accounting to pharmacy reimbursement trends, Stock Titan delivers context investors actually use—backed by real-time updates, comprehensive coverage of every form, and expert commentary that turns regulatory language into actionable clarity.
Mitesco, Inc. filed its Q3 2025 report, showing severe liquidity and ongoing restructuring. The company ended the quarter with cash and cash equivalents of $321 and a stockholders’ equity deficit of $(23,785,020). Management disclosed “substantial doubt” about its ability to continue as a going concern.
Q3 revenue was $3,000 (down from $23,500 a year ago) as resources shifted to software projects. Operating expenses were $1,014,422, and the company reported a Q3 net loss of $(3,202,971), driven by accretion and revaluations tied to its Series A preferred and a $(500,000) legal settlement loss. For the nine months, revenue was $38,700 and net income was $159,981, aided by a $3,513,655 gain on derivative revaluation.
Current liabilities totaled $17,583,270, including legal settlements of $3,322,834 and Series A preferred liabilities presented at a $13,397,721 present value. The company issued common shares for redemptions and services and recorded stock-based compensation of $824,649 year-to-date. As of November 13, 2025, common shares outstanding were 15,093,055.
Mitesco, Inc. (MITI) entered a secured financing and unregistered equity securities transaction. The company issued a Senior Secured 10% Original Issue Discount Convertible Promissory Note with potential total funding of $1,000,000, beginning with $250,000 funded on October 31, 2025. The 18‑month note requires repayment of $275,000 reflecting the 10% OID, bears no interest unless in default, and is convertible into common stock at $0.15 per share, subject to adjustments.
The note may be prepaid at 110% of the outstanding principal. Obligations are guaranteed by subsidiaries, secured by a pledge of subsidiary securities, and carry a first‑priority senior security interest in all company assets. The securities were sold pursuant to Section 4(a)(2) and Regulation D and are not registered under the Securities Act.
Mitesco, Inc. (MITI) reported an insider transaction by CEO and director Mack R. Leath. On 09/22/2025, Leath acquired 8,787 shares of common stock at $0.18 per share. Following this trade, he beneficially owned 394,327 shares, held directly. A footnote states this total includes 100,000 shares held by a family member.
FAQ
What is the current stock price of Mitesco (MITI)?
What is the market cap of Mitesco (MITI)?
